US 2026/0284127 A1Published application

Compositions of bioactives in cordyceps and methods of delivery for the treatment of acute and long covid

OwnerYun Kau TAM, Chih-yuan TSENGinventors

Life of this patent

Estimating the term…

Abstract

This invention discloses a composition of active ingredients found in the genus of cordyceps, in defined ratios, the combination of ingredients, when administered orally in an appropriate dosage form, are effective in the treatment of COVID and Long COVID.

Claims15

Dependent claims

A composition for the treatment of COVID and/or long COVID, comprising cordycepin, adenosine and a Cordyceps fungi extract comprising polysaccharides.

Dependencies are inferred from the claim text.

Facts

Application: 19/475,537Filed 17 Apr 2024
Priority: 17 Apr 2023
Published: 24 Sep 2026
Term ends: Not estimatedThe source records don’t support an estimate.

Classification7 codes

A61K 36/068
Clavicipitaceae: cordyceps
A61K 31/7076
Containing condensed or non-condensed pyrimidines: containing purines, e.g. adenosine, adenylic acid
A61K 31/715
Carbohydrates; Sugars; Derivatives thereof: polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic…
A61P 25/00
Drugs for disorders of the nervous system

Family

Application63/496,538Us provisional application · filed 17 Apr 2023
Application63/496,611Us provisional application · filed 17 Apr 2023
US 2026/0284127 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results